CERo Therapeutics Holdings, Inc. (CERO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -2.76M | -3.81M | -3.21M | -4.62M | -4.45M | -1.54M | -2.76M | -3.54M | -5.08M | -186.61K | -1.32K | -2.07M |
| Operating CF Margin % | - | - | - | - | - | -132.44% | - | - | - | - | - | - |
| Operating CF Growth % | 37.89% | -147.16% | -16.2% | -30.68% | 12.49% | -725.31% | -209172.46% | -70.55% | -253.6% | 49.98% | 99.24% | -776.29% |
| Net Income | -5.89M | -4.54M | -4.86M | -5.42M | -5.11M | -1.05M | -4.23K | -2.45M | -2.3M | -282.76K | -1.35K | -2.09M |
| Depreciation & Amortization | 276.14K | 276.14K | 272.77K | 267.66K | 269.48K | 284.63K | 297 | 293.25K | 288.16K | 0 | 281 | 277.45K |
| Stock-Based Compensation | 1.62M | 1.12M | -515.43K | 890.63K | 461.2K | -1.4M | 404 | 1.4K | 101 | 0 | -138 | 27.28K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.01M | -758.13K | 1.36M | 0 | 0 | -64.54K | -2.13M | -1.96M | -2.16M | -110.99K | -42.58K | 445.86K |
| Working Capital Changes | 217.45K | 92.97K | 530.65K | -364K | -70.41K | 691.72K | -627.76K | 576.39K | -905.37K | 207.14K | 42.46K | -35.5K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 105.95K | 503.56K | 864.54K | -166.01K | 727.91K | 1.36M | -600.1K | -265.01K | -286.49K | 0 | 205.9K | 209.19K |
| Cash from Investing | 0 | 0 | 500K | 0 | 0 | -4 | 0 | 0 | 0 | -13.82M | 5.69M | 285.24K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -4 | 0 | 4 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | 0% | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4 | 0 | 73.31K | 610.14K | 285.24K |
| Cash from Financing | 1.96M | 3.45M | 1.42M | 2.72M | 6.32M | 1.49M | 2.49M | 2.59M | 7.16M | -27.68K | 0 | 566.51K |
| Debt Issued (Net) | 1.5M | 0 | 0 | 0 | 0 | 19.71K | -150.9K | -149.34K | -19.71K | 0 | 0 | 605.23K |
| Equity Issued (Net) | 456.17K | 3.38M | 1.6M | 1.01M | 6.32M | 1.59M | 2.64M | 2.74M | 6.76M | -27.84M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -27.84M | -5.64M | 0 |
| Other Financing | 0 | 69.09K | -174.5K | 1.71M | 0 | -121.99K | 0 | 0 | 421.78K | 27.82M | 0 | -38.72K |
| Net Change in Cash | -804.89K | -359.69K | -1.28M | -1.9M | 1.88M | -53.14K | -266.82K | -946.08K | 2.99M | 1.48M | 13.78K | -1.51M |
| Free Cash Flow | -2.76M | -3.81M | -3.21M | -4.62M | -4.45M | 4.15M | -1.32M | -3.54M | -5.08M | -186.61K | -256.12K | -2.07M |
| FCF Margin % | - | - | - | - | - | 356.51% | - | - | - | - | - | - |
| FCF Growth % | 37.89% | -191.82% | -143.13% | -30.7% | 12.49% | 2321.54% | -414.71% | -70.53% | -253.6% | 49.98% | -46.9% | -776.29% |
| FCF per Share | -0.10 | -0.90 | -2.53 | -9.47 | -25.94 | 34.32 | -53.08 | -436.75 | -690.88 | -25.38 | -34.83 | -282.09 |
| FCF Conversion (FCF/Net Income) | 0.47x | 0.84x | 0.66x | 0.85x | 0.87x | -1.24x | 0.65x | 1.44x | 2.21x | 0.66x | 0.00x | 0.99x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |